New treatment strategy aims to stop rare liver cancer
An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver. Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...
Tag: philanthropy
Understanding the accomplice cells that help drive pancreatic cancer
Mara Sherman’s award-winning research is uncovering the role of non-cancer cells that support tumor growth in pancreatic ductal adenocarcinoma. The pancreatic cancer survival rate, averaging...
An elaborate clinical trial aims a multitude of targeted therapies at one formidable cancer
A $10 million gift from The Harry T. Mangurian Jr. Foundation will help The Leukemia & Lymphoma Society expand the Beat AML Master Trial underway at the OHSU Knight Cancer Institute and other...
Check out the Knight Cancer pilot project award winners
Preventing skin cancer with a DNA-repair enzyme. Understanding how microRNAs modify cancer immunity. Using zebrafish embryos to rapidly assess toxicity of anticancer drug combinations. These are...
With foundation help, an Oregon doctor roots out low-value medical practices
Physicians have started to face up to an uncomfortable truth: their profession has often embraced new treatments that don't really help patients. "When you look at the balance of benefit and harm,...
First in philanthropy: Phil and Penny Knight
Phil Knight and Brian Druker, M.D., on "Good Morning America" in 2015. Nike co-founder Phil Knight and his wife Penny ranked no. 1 in The Chronicle of Philanthropy list of Americans who donated...